top of page
Executive Spotlights

Baxter to sell biopharma unit for $4.25 billion

Deerfield, IL, May 8, 2023 (Reuters) -- Baxter International Inc. has agreed to sell its biopharma solutions unit to a private-equity group for $4.25 billion, with the proceeds being used to pay down debt from its acquisition of Hill-Rom Holdings. This comes as medical device manufacturers struggle with supply-chain shortages and increased costs due to the pandemic.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Commentaires


Life Science Headlines
bottom of page